Skip to content

Clinical Observation of QiLuJianShen Granule in Improving Senile Debilitating Syndrome

Clinical Observation of QiLuJianShen Granule in Improving Senile Debilitating Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010667
Enrollment
Unknown
Registered
2017-02-17
Start date
2017-02-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Senile Debilitating Syndrome

Interventions

therapy group:Taking QiluJianShen granules , boiled water, a 12g, 2 times a day. Intervention for 6 months.
Control group:Taking placebo particles (Qi Er Jian Shen granules effective ingredients of 1/20, made of odor formulations and other aspects of treatment with the same drug), served the same as above.

Sponsors

Affiliated Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. aged ? 65 years old; 2. Be able to communicate properly and complete the body assessment test; 3. In line with the indications of senile debilitating syndrome, refer to Fried and other definitions of the criteria for weakness; 4. In line with the diagnosis of kidney qi deficiency syndrome, with reference to the State Administration of Traditional Chinese Medicine in 1994 promulgated the "Chinese medicine diagnosis and treatment standards".

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the criteria for inclusion; 2. does not belong to QiluJianShen granules within the scope of the case, or a clear card or merger card; 3. nearly 1 month to take other with the benefits of blood, liver and kidney, strong tendons and muscles, flat and warm the role of drugs; 4. Patients participated in other clinical trials within 3 months; 5. allergies and allergies to a variety of drugs; 6. Suspicion or the history of drug abuse, or according to the judge's judgment, with the possibility of reducing the enrollment or complication of the group of other lesions or circumstances, such as frequent changes in the working environment and so easy to cause loss of the situation; 7. combined liver and kidney, hematopoietic system, endocrine system and other serious primary disease and mental illness; 8. critically ill (such as severe cardiac insufficiency, severe infection and cancer, etc.), it is difficult to Qi Erjian granules of the effectiveness and safety of the exact evaluation of those who make.

Design outcomes

Primary

MeasureTime frame
grip strength;Timed get up and go(TUG);five times sit to stand(FTSS);one-leg standing test(OLS);Symptoms of Kidney Deficiency Syndrome;Quality of Life Scale;

Countries

China

Contacts

Public ContactShen Yan

Affiliated Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Sheny26@126.com+86 18930568212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026